(53) Key regulatory genes and pathways implicated in glioma development include TP53 mutations, loss of NF1 function, dysregulation of AKT, Notch signaling and Wnt pathway and TGF-β pathway (Figure 2). This evidence concerns the gene AKT1 and central nervous system cancer.